Italia markets closed

DYN Dec 2024 40.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,80000,0000 (0,00%)
Alla chiusura: 11:00AM EDT
Schermo intero
Chiusura precedente4,8000
Aperto4,8000
Denaro3,6000
Domanda5,4000
Prezzo d'esercizio40,00
Scadenza2024-12-20
Min-Max giorno4,8000 - 4,8000
Contratto - Min-MaxN/D
Volume1
Open Interest24
  • GlobeNewswire

    Dyne Therapeutics to Present at October Investor Conferences

    WALTHAM, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to present at the following investor conferences in October: Chardan’s 7th Annual Genetic Medicines Conference, fireside chat on Tuesday, October 3, 2023 at 11:00 a.m. ET in New York Jefferies Inaugural Biotech

  • GlobeNewswire

    Dyne Therapeutics Receives FDA Orphan Drug Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1

    - On Track to Report Initial Data from the Global, Multiple Ascending Dose Phase 1/2 ACHIEVE Clinical Trial in the Second Half of 2023 - WALTHAM, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for DYNE-101 for

  • GlobeNewswire

    Dyne Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference

    WALTHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference being held in New York on Monday, September 11, 2023 at 4:15 p.m. ET. A live webcast will be available in the Inv